Rv1630 - c.126C>T
Drug resistance types
1 Sensitive
4 RR-TB
0 HR-TB
12 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
3 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.2 | 1 |
| lineage4.3.3 | 2 |
| lineage1.2.2 | 1 |
| La3;lineage4 | 1 |
| lineage4.2.2.2 | 1 |
| lineage4.1.1.1 | 2 |
| lineage2.2.1 | 2 |
| lineage4.9 | 2 |
| lineage4.4.1.1.1 | 2 |
| lineage4.1.1.3 | 1 |
| lineage4.4.1.1 | 1 |
| lineage4.8.1 | 2 |
| lineage4.1.1.3.1;lineage4.9 | 1 |
| lineage4.1.2 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 20 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| SRR11342664 | MDR-TB | lineage2.2.2 | None |
| SRR11342649 | MDR-TB | lineage4.3.3 | None |
| ERR4818126 | Other | lineage1.2.2 | None |
| SRR11342636 | MDR-TB | lineage4.3.3 | None |
| ERR3283028 | Other | La3;lineage4 | None |
| SRR11342687 | RR-TB | lineage4.2.2.2 | None |
| SRR11342651 | MDR-TB | lineage4.1.1.1 | None |
| SRR11342653 | MDR-TB | lineage2.2.1 | None |
| ERR4796351 | Sensitive | lineage4.9 | None |
| SRR11342644 | MDR-TB | lineage4.4.1.1.1 | None |
| SRR11342647 | MDR-TB | lineage4.1.1.3 | None |
| ERR4818851 | RR-TB | lineage4.4.1.1 | None |
| SRR11342693 | MDR-TB | lineage4.8.1 | None |
| SRR11342662 | MDR-TB | lineage4.8.1 | None |
| SRR5007161 | RR-TB | lineage4.1.1.3.1;lineage4.9 | None |
| SRR11342642 | MDR-TB | lineage4.1.1.1 | None |
| ERR108125 | RR-TB | lineage4.9 | None |
| SRR11342682 | Other | lineage4.1.2 | None |
| SRR11342660 | MDR-TB | lineage2.2.1 | None |
| SRR11342696 | MDR-TB | lineage4.4.1.1.1 | None |
